We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
NYSE:ABBV
​
​
logo

AbbVie Inc. (ABBV)

NYSE • ABBV • US00287Y1091

Ex-dividend 15 Jan 27 · 1.82 USD (special)
294.83Last close
Market Closed
Ex-dividend 15 Jan 27 · 1.82 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimated 0.9% of free float sold short, 3 days to cover, cost to borrow 0.44%. Sign up for live short interest data.

Market Cap

521b USD | # 24 in US

Volume

4.76m shares | 1.27b USD

Shares Outstanding

1.77b

Free Float Shares

99.82% | 1.76b

DB:4AB|
DB:4AB0|
XTRA:4AB|
LSE:0QCV|
TSX:ABBV|
BOVESPA:ABBV34|
BIT:1ABBV|
BASE:ABBV|
BASE:ABBV|
BASE:ABBVD|
WBAG:ABBV|
SET:ABBV19|
SET:ABBV80

News

ABBV key data

AbbVie Inc. (NYSE: ABBV) has a market capitalization of $521.15B. Last close $294.83 (as of 2026-11-05); 52-week range $190.75 to $298.74. ORTEX data as of 2026-10-21: short interest was 0.87% of free float, 3 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.

Latest on ABBV

  • Jul 24, 2026AbbVie at $257 — Three Days From the Q2 Print
All ABBV news on ORTEX News
  • ABBV news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.